AssetMark Inc
SCMP

AssetMark Inc’s Sucampo Pharmaceuticals, Inc. SCMP Stock Holding History

AssetMark Inc’s Portfolio SCMP Stock Details SCMP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q1 		– Sell
-8
Closed – – 2271
2017
Q4 		$0 Buy
+8
New +$98 ﹤0.01% 2290

Other funds holding SCMP

GT
Glenmede Trust Philadelphia, Pennsylvania $20.4B AUM
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
AIM
Advantage Investment Management Cedar Rapids, Iowa $128M AUM 0.94% 1-Year Est. Return

AssetMark Inc's SCMP Position: Q1 2018 in Review

AssetMark Inc sold out of Sucampo Pharmaceuticals, Inc. (SCMP) in Q1 2018, closing a stake of 8 shares.

AssetMark Inc first reported a position in SCMP in Q4 2017 and held it in 1 quarter. The position peaked at $0 in Q4 2017. 3 funds tracked by Wall St. Rank hold SCMP as of Q1 2018.

  • AssetMark Inc reported no remaining Sucampo Pharmaceuticals, Inc. position as of Q1 2018 after selling out during the quarter.
  • AssetMark Inc sold 8 Sucampo Pharmaceuticals, Inc. shares in Q1 2018.
  • AssetMark Inc first reported a position in Sucampo Pharmaceuticals, Inc. in Q4 2017 and held it in 1 quarter.
  • AssetMark Inc's Sucampo Pharmaceuticals, Inc. position peaked at $0 in Q4 2017.
  • 3 funds tracked by Wall St. Rank held Sucampo Pharmaceuticals, Inc. as of Q1 2018.

Based on AssetMark Inc's 13F filing for Q1 2018, filed 16 May 2018.